Midorikawa Yutaka, Ishikawa Takashi, Kubota Keiichi, Mori Masaya, Takayama Tadatoshi, Makuuchi Masatoshi
Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan.
Hepatogastroenterology. 2002 Jul-Aug;49(46):1098-101.
This report describes a 63-year-old man with a large adenomatous hyperplasia that had been followed over 10 years without any apparent change of size or profile, but grew rapidly after completion of interferon therapy. This patient was a sustained responder, in whom serum alanine aminotransferase levels remained within the normal range and the serum hepatitis C virus-RNA level was undetectable after completion of interferon therapy. However, the tumors, located in segments 5 and 8 of the liver, which had both been followed as adenomatous hyperplasia, grew rapidly two months after completion of interferon therapy; imaging modalities revealed that the former was a typical hepatocellular carcinoma and the latter a large adenomatous hyperplasia. The patient underwent right paramedian sectoriectomy of the liver. Histological examination showed that the tumor in segment 8 had mosaic proliferation of hepatocytes without fibrosis, indicating adenomatous hyperplasia, in which a small focus of well-differentiated hepatocellular carcinoma was present. This case suggests that even in sustained responders to interferon, administration of this drug cannot suppress malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. One year after surgery, the patient is doing well without signs of recurrence.
本报告描述了一名63岁男性,患有巨大腺瘤样增生,随访10年其大小和形态无明显变化,但在干扰素治疗结束后迅速生长。该患者是持续应答者,干扰素治疗结束后血清丙氨酸转氨酶水平保持在正常范围内,血清丙型肝炎病毒RNA水平检测不到。然而,位于肝脏第5和第8段的肿瘤,之前一直被视为腺瘤样增生,在干扰素治疗结束两个月后迅速生长;影像学检查显示,前者为典型肝细胞癌,后者为巨大腺瘤样增生。患者接受了肝脏右旁正中扇形切除术。组织学检查显示,第8段的肿瘤有肝细胞镶嵌样增生,无纤维化,提示腺瘤样增生,其中存在一小灶高分化肝细胞癌。该病例表明,即使是干扰素治疗的持续应答者,使用这种药物也无法抑制腺瘤样增生向肝细胞癌的恶变。手术后一年,患者情况良好,无复发迹象。